Adlai Nortye USA Inc

Adlai Nortye is a global clinical-stage biopharmaceutical company with several innovative late-stage immuno-oncology medicines in its pipeline. Our focus is to provide new options designed to transform historically hard-to-treat cancers into manageable conditions in the near-term -- so that patients are able to live longer and better -- while at the same time pursuing science that can lead to a cure. As a rapidly growing multinational company, we are working across borders and partnering around the world to change how cancer is treated.